This intrusive, but common phenomenon can take over your life, affecting your state of mind and eating habits. Weight-loss drugs show promise in quieting these thoughts.

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

There's a new player in the running game, and it's not the latest carbon-plated shoe or fancy GPS watch. GLP-1 medications ...

The hypothalamus — the brain region that defends ... trick the brain into losing weight? The drug mimics GLP-1. By binding to GLP-1 receptors in the brainstem, it stimulates the neural circuits ...

These drugs imitate the actions of GLP-1. They target the appetite control centre in the hypothalamus area of the brain to reduce hunger pangs; slow down the rate the food leaves the stomach, leaving ...

The arrival of GLP-1 analog drugs (such as Wegovy) marked a huge shift in the weight-loss drug market. These drugs have been shown to lead to significant weight loss in users—as much as 15% or ...

The majority of patients may safely take glucagon-like peptide 1 receptor agonists (GLP-1 RAs) before elective surgery and ...

Pendulum Therapeutics latest innovation comes in the form of a GLP-1 probiotic, acting as an appetite suppressor and healthy ...

Naturally occurring GLP-1 activates the hypothalamus, a part of the brain that controls aspects of appetite and food intake, says Zhiping Pang, a neuroscientist at Robert Wood Johnson Medical ...

Semaglutide targets the areas in the brain that regulate appetite, particularly the hypothalamus, which is responsible for controlling hunger and satiety. By activating the GLP-1 receptors in ...

Over 1 billion people worldwide are overweight and over 300 million are obese. The hypothalamus is the main ... ARC: Arcuate nucleus; CCK = Cholecystokinin; GLP = Glucagon-like peptide; LHA ...